Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001723643-25-000011
Filing Date
2025-05-29
Accepted
2025-05-29 16:33:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6586
2 exhibit1.htm EX-1 2808
3 exhibit2.htm EX-2 641
  Complete submission text file 0001723643-25-000011.txt   11799
Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Subject) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92480 | Film No.: 251004003
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 280 PARK AVENUE, 5TH FLOOR WEST NEW YORK NY 10017
Business Address 280 PARK AVENUE, 5TH FLOOR WEST NEW YORK NY 10017 6465610434
Shay Capital LLC (Filed by) CIK: 0001723643 (see all company filings)

EIN.: 822647087 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G